David R Hathaway

This inventor holds 12 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Amylin Pharmaceuticals, Inc., Indiana University, Astrazeneca Pharmaceuticals LP. Active years: 1992-2013.

USPTO Granted Patents = 12 (Patent Applications = 2)

% Patents Active = 25.0

EPO Patents = 2

Average Co-Inventor Count = 2.4

ph-index = 11

Forward Citations = 959(Granted Patents)

Location History:

Indianapolis, IN (US) (1992 - 1994)
San Diego, CA (US) (2011)
Lincoln, NE (US) (2006 - 2013)

Company Filing History:

7 out of 164

Amylin Pharmaceuticals, Inc.

Astrazeneca Pharmaceuticals LP

patents

where one patent can have more than one assignee

Years Active: 1992-2013

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8389473 - Treatment of cardiac arrhythmias (2013-03-05),

2. 7960341 - Methods and compositions for treating polycystic ovary syndrome (2011-06-14),

3. 7888314 - Compositions and methods for treating peripheral vascular disease (2011-02-15),

4. 7790681 - Treatment of cardiac arrhythmias with GLP-1 receptor ligands (2010-09-07),

5. 7686821 - Apparatus and method for positive closure of an internal tissue membrane opening (2010-03-30),

6. 7670349 - Apparatus and method for positive closure of an internal tissue membrane opening (2010-03-02),

7. 7259136 - Compositions and methods for treating peripheral vascular disease (2007-08-21),

8. 7105490 - Methods and compositions for treating polycystic ovary syndrome (2006-09-12),

9. 7105489 - Methods and compositions for treating polycystic ovary syndrome (2006-09-12),

10. 5306250 - Method and apparatus for intravascular drug delivery (1994-04-26),

11. 5171217 - Method for delivery of smooth muscle cell inhibitors (1992-12-15),

12. 5116864 - Method for preventing restenosis following reconfiguration of body (1992-05-26),

Title: David R Hathaway: Innovator in Cardiac and Reproductive Health

Introduction

David R Hathaway is a prominent inventor based in Lincoln, NE (US), known for his significant contributions to medical science. With a total of 12 patents to his name, Hathaway has focused on developing innovative treatments for various health conditions, particularly in the fields of cardiology and reproductive health.

Latest Patents

Hathaway's latest patents include groundbreaking work on the treatment of cardiac arrhythmias. His inventions involve compositions that include compounds binding to receptors for glucagon-like peptide-1 (GLP-1) and related agonists. These compounds are designed to prevent and treat arrhythmias associated with cardiac ischemia, ischemia-perfusion, and congestive heart failure. Additionally, he has developed methods and compositions for treating polycystic ovary syndrome (PCOS), which involve administering GLP-1 and its analogs to affected individuals.

Career Highlights

Throughout his career, Hathaway has worked with notable organizations such as Amylin Pharmaceuticals, Inc. and Indiana University. His work has significantly advanced the understanding and treatment of complex medical conditions, showcasing his dedication to improving patient outcomes.

Collaborations

Hathaway has collaborated with esteemed colleagues, including Keith Leonard March and Robert L Wilensky. These partnerships have further enriched his research and development efforts, leading to innovative solutions in healthcare.

Conclusion

David R Hathaway's contributions to medical innovation, particularly in cardiac and reproductive health, highlight his role as a leading inventor. His patents and collaborations reflect a commitment to advancing medical science and improving the lives of patients.